Company Directory / research
PrivateFor profitresearchGothenburg, Sweden
Umecrine Cognition
Umecrine Cognition has develops drugs against central nervous system neurological disorders, CNS caused by endogenous CNS active steroids.
- Founded
- 2006 20 years ago
- Staff
- 1-10 band, as listed
- Followers
- - on LinkedIn
- Funding
- $50M as listed, currency not stated
Set against six million companies
Size
1-10 people: larger than 0% of companies with a size listed
Age
20 years old.
Reach
Website ranked #10,188,049 in the world for traffic, about 248 visits a month.
What it does
BiotechnologyHealth CarePharmaceutical
Funding, as listed
$50M currency not stated
- Rounds3
- LatestConvertible note, Nov 2023
- Investors6, 1 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Umecrine Cognition, field by field. Contact details are held but never shown.
The company
- Name
- Umecrine Cognition
- Type
- For profit
- Status
- Private
- Founded
- 2006
- Founders
- Torbjorn Backstrom
- Industry
- research
- Categories
- Biotechnology, Health Care, Pharmaceutical
Where
- City
- Gothenburg
- Country
- Sweden
- Markets
- European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 1-10
- Web traffic rank
- #10,188,049
- Monthly web visits
- 248
Funding, as listed
- Total
- 50,400,000 (currency not stated)
- Rounds
- 3
- Latest round
- Convertible note
- Latest round date
- Nov 2023
- Investors
- 6
- Lead investors
- 1
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Umecrine Cognition may be growing as it is listed among major market players in the hepatic encephalopathy drug market, indicating a recognized presence in the industry. The company's inclusion in market size analyses and forecasts for the period up to 2031 suggests that it is part of a sector that is expected to experience growth. Furthermore, the repeated mention of Umecrine Cognition in various reports alongside other key industry players implies that it is actively involved in the market and may be contributing to the projected industry growth.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in Sweden.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 41,197 companies in Sweden and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.